TILLIT adds five funds to platform
Funds include biotech, global, US, multi asset, and UK exposures
Funds include biotech, global, US, multi asset, and UK exposures
However, growth versus value argument is not as clear cut as it once was
Decision follows exit of fund manager Jeremy Gleeson
Total number of funds on platform reaches over 100
Two funds remained in universe following review